Updated 6/5/2020: As part of the Medical School Research Reactivation Process guidelines, a wave 2 ramp-up will begin on Monday, June 8th for labs and staff who conduct research within MSRB 1, 2, 3, MBNI, NCRC 14, 23, 35, 36, 60, 90 and NCRC 26 VIVARIUM only. The Vector Core has been approved to reopen for labs and staff who conduct research within these approved buildings.
For the latest Vector Core updates, including new operating procedures, please visit the BRCF Research Reactivation Guidelines.
The Vector Core
produces biological products (gene transfer vectors) that facilitate the transfer of specific genes into either normal or aberrant cells. The Vector Core also provides intellectual and technical advice to researchers regarding the optimal use of these systems. Gene transfer vectors require special handling precautions and manufacturing systems that lend themselves to a core structure that optimizes efficiencies of scale and cost to the research community.
To begin work with the Vector Core, you will first need to register with MiCores and complete training. Please see the Training page for more information on how to get started.
For questions regarding your specific needs or project goals please contact Vector Core Director, Tom Lanigan, to set up a consultation.
- Provide a Core laboratory for the construction, purification, and characterization of recombinant vectors containing genes relevant to the study of disease models for use as in vitro and in vivo gene transfer reagents. These systems include both non-viral (expression plasmid) and viral (recombinant lentivirus, recombinant retrovirus, and recombinant adenovirus) technologies.
- Collaborate closely with researchers to ensure the Vector Core provides the platforms our customers require, and to institute the use of new technologies.
- Maintain qualified staff and provide high quality, cost-effective products to our researchers.
Access to old AGC Sanger data
The Michigan Advanced Genomics Core stopped performing Sanger Sequencing and Fragment Analysis in mid-March, 2020. Consequently, Sanger data from the AGC will be available until December 1, 2020, at which time it will be permanently deleted from our system. This grace …DNA Blog Posts
Dana Dolinoy Awarded Grant from NIEHS RIVER Program
This article was originally published on RogelCancerCenter.org on June 24, 2020. Dana Dolinoy, Ph.D., received a $6.9 million R35 award from the National Institute of Environmental Health Sciences. The award is granted from the NIEHS Revolutionizing Innovative, Visionary Environmental Health …Case Studies & Research Profiles Breaking News